MOTS-C Mitochondrial-Derived Peptide Research Overview

MOTS-C (mitochondrial open reading frame of the 12S rRNA‐c) is a high-purity, research-grade mitochondrial-derived peptide (MDP) composed of 16 amino acids and encoded by the mitochondrial genome. It is a key experimental tool for investigating mitochondrial–nuclear communication, metabolic regulation, and cellular stress adaptation in vitro and in vivo.

Molecular Composition and Mechanistic Profile

• Plays a critical role in cellular metabolic regulation and energy homeostasis, particularly in skeletal muscle and other metabolically active tissues.

• Translocates from mitochondria to the nucleus under metabolic stress, where it regulates nuclear gene expression related to mitochondrial

• biogenesis, antioxidant responses, proteostasis, and metabolic adaptation.

  Signals in an AMPK‐dependent manner, amplifying glucose uptake, inhibiting the folate cycle and de novo purine biosynthesis during metabolic stress, and shifting cellular metabolism toward enhanced stress resilience and efficient fuel use.

These properties support its classification as a “mitochondrial hormone” or mitokine that coordinates metabolism within and between cells.

Integrated Research Applications

• MOTS-C is used across multiple domains of metabolic, cardiovascular, musculoskeletal, and aging research. Representative experimental areas include:

• Metabolic disease and obesity: Murine models show that MOTS-C improves insulin sensitivity, enhances skeletal muscle glucose uptake, promotes lipid utilization, and reduces diet‐induced obesity while improving glucose tolerance.

• Aging and longevity: Preclinical work links MOTS-C to improved metabolic responses to aging, enhanced stress adaptation, and potential longevity effects via regulation of mitochondrial biogenesis, antioxidant defenses, and proteostasis.

• Cardiovascular and vascular calcification: MOTS-C exposure has been reported

  to reduce oxidative stress, improve vascular wall structure, decrease disordered

  elastic fibers, and attenuate vascular calcification and endothelial dysfunction.

• Musculoskeletal function and bone: In skeletal muscle, MOTS-C activation of AMPK pathways increases glucose transporter expression, improves muscle

  metabolism, and supports contractile function; in bone, it has been reported to promote type I collagen synthesis in osteoblasts via TGF‐β/SMAD signaling in osteoporosis models.

• Inflammation, pain, and immune modulation: Experimental data suggest analgesic and anti-inflammatory actions via AMPK activation and inhibition of MAP kinase/c‐Fos pathways, with potential applications across cardiovascular disease, insulin resistance, and inflammatory states.

  Collectively, these models position MOTS-C as a central node for integrating mitochondrial signaling with systemic metabolic control.

Analytical Validation, Formulation, and Product Care

• Research MOTS-C products from these suppliers are typically provided as lyophilized peptide at defined content per vial (e.g., 5 mg or 10 mg). Key quality and handling features include:

• Purity: Commonly ≥98–99%, confirmed by high-performance liquid chromatography (HPLC).

• Formulation: Shipped in lyophilized or powder form and intended to be reconstituted to liquid immediately prior to research use.

  Product care guidance emphasizes: storing in a cool, dry place away from light; refrigerating after constitution; and freezing at approximately −20 °C for longer-term storage to maintain structural integrity.

NextGenPeps supplies MOTS-C as a research-grade peptide intended solely for use in laboratory investigations, including in vitro assays and approved animal models. This compound is not approved for human consumption or clinical application and must only be used in accordance with institutional research protocols.